Skip to content

About Us
Our Science
Clinical Programs
News
Publications
Contact Us

About Us
Our Science
Clinical Programs
News
Publications
Contact Us

Leadership

Steven Cordovano

Leadership / serrao6

VP, Corporate Development and Communications

Steven Cordovano Read More »

Lester Kobzik, MD

Leadership / serrao6

Chief Scientific Advisor

Lester Kobzik, MD Read More »

Howard Levy, M.B.B.Ch., Ph.D., M.M.M.

Leadership / Susan Serrao

Chief Medical Officer

Howard Levy, M.B.B.Ch., Ph.D., M.M.M. Read More »

Valerie Ceva, MBA

Board, Leadership / serrao6

Chief Operating Officer
Board Member

Valerie Ceva, MBA Read More »

Susan L. Levinson, PhD.

Board, Leadership / serrao6

Chief Executive Officer
Board Member

Susan L. Levinson, PhD. Read More »

Recent News

August 20, 2025: BioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)

August 20, 2025

June 17, 2025: BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

June 17, 2025

Company Location

NJ Bioscience Center
685 US Route 1
North Brunswick, NJ 08902

Follow Us

Twitter Linkedin Youtube

©2025 BioAegis® Therapeutics Inc.
Careers | Privacy Policy | Code of Business Conduct and Ethics | Terms of Use